NL-OMON43122已完成不适用
A phase 1, open-label study to characterize the absorption, metabolism, and excretion of 14C-JNJ-53718678 after a single oral dose in healthy adult male subjects - JNJ-53718678 ADME study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male subjects
- •- 18 - 55 yrs, inclusive
- •- BMI: 18.0 to 30.0 kg/m2, extremes included
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. Subject has received an experimental drug or experimental vaccine, or has used an experimental medical device within 1 month or within a period less than 10 times the drug*s half-life, whichever is longer, before scheduled study drug administration. Subject has donated blood or blood products or has had substantial loss of blood within 3 months before study drug administration or intention to donate blood or blood products during the study.
研究者
相似试验
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism and excretion of 14C-JNJ-63623872 after a single dose in healthy male subjectsInfluenza ARNA-virus10047438NL-OMON42724Janssen-Cilag6
已完成
不适用
A Phase 1, Open Label Study to Characterize the Absorption, Metabolism, and Excretion of 14C JNJ 67953964 After a Single Dose in Healthy Adult Male Participants10027946DepressionNL-OMON51737Janssen-Cilag International NV8
已完成
不适用
A phase I, open label study to investigate the absorption, metabolism and excretion of 14C-ESN-364 in healthy menopausal female volunteers.NL-OMON46563Ogeda6
已完成
1 期
A mass-balance study of [14C]KDT-3594 in healthy adult maleHealthy conditionJPRN-jRCT2071220057Shimizu Yoshitaka8
已完成
不适用
A phase I, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]QLT091001 following single oral dose in healthy male subjectsNL-OMON35776QLT Inc.6